Kane Biotech to sell its STEM Animal Health for C$11.5 million

Kane Biotech (TSXV:KNE) is selling its entire interest in STEM Animal Health to a third-party pharmaceutical company for C$11.5 million.

Cannabis stock jumps on news its products are coming to Canada

Ovation Science Inc. (CSE:OVAT) signs an exclusive licensing agreement for its products in Canada with Ripco Processing Inc.
The Market Online Video

Emerging opportunity in a growing, high-value dermatological market

Kane Biotech (TSXV:KNE) engages in the development and commercialization of products that prevent and remove microbial biofilms.

Buzz on the Bullboards: Looking for volatility-proof stocks?

Investors saw developments in Canadian and U.S. stock markets, with attention on decisions made by central banks and moves in key sectors.

Medicenna shares preclinical data on treatment targeting tumours

Medicenna Therapeutics revealed new preclinical data from its MDNA113 drug candidate, the company's treatment targeting IL-13Ra2.

Red Light Holland reports record psilocybin shipment

Psychedelics stock Red Light Holland (CSE:TRIP) exports 5 kilograms of natural psilocybin truffles to CCrest Laboratories in Montreal.

This company’s Photo Dynamic Therapy is transforming cancer treatment 

Theralase (TSXV:TLT) reveals the patent will protect the company’s PDC technology in treating patients with a cancer vaccine.

Theralase patents new cancer vaccine in Canada

Microcap stock Theralase Technologies (TSXV:TLT) secures a Canadian patent for a game-changing cancer vaccine.

AI healthcare stock taps industry veteran for advisory board

AI software developer NetraMark Solutions (CSE:AIAI) appoints industry veteran Jeff Huntsman to its strategic advisory board.

Buzz on the Bullboards: Highlights from Bay Street to Wall Street

On Bay Street, the Toronto Stock Exchange witnessed intriguing developments, while Wall Street saw its own array of fluctuation.

Avicanna launches 10% CBD (THC free) formula in Canada

Avicanna (TSX:AVCN) launches RHO Phyto Micro Drop 100, a 10 per cent CBD (THC free), proprietary oral formulation in Canada.

Theratechnologies phases down preclinical oncology research

Biopharmaceutical company Theratechnologies (TSX:TH) announced it will phase down its preclinical oncology research activities.

Fusion Pharmaceuticals shares soar 97% after AstraZeneca takeover

Fusion Pharmaceuticals' (NDAQ:FUSN) shares are up 97 percent after announcing it will be acquired by AstraZeneca for US$2.4 billion.

Sona Nanotech files patent application for photothermal light device

Sona Nanotech (CSE:SONA) submits a patent application to the U.S. Patent and Trademark Office for its proprietary photothermal light device.